The Trump administration is acting to remove another regulatory barrier to agricultural biotechnology by proposing to streamline EPA's oversight of pest-resistant plants. But there's little sign of progress on reforms to FDA’s regulation of gene-edited animals.
To view this article, please login
. If you are not a current subscriber, you may sign up for a trial or view other subscription options here